COVID and the Heart

What clinicians want you and your loved ones to know.

1:42 PM

Author | Johanna Younghans

Editor's note: Information on the COVID-19 crisis is constantly changing. For the latest numbers and updates, keep checking the CDC's website. For the most up-to-date information from Michigan Medicine, visit the hospital's Coronavirus (COVID-19) webpage.

Frankel Cardiovascular Center specialists at Michigan Medicine know all too well about the worry and constant discussions swirling around about COVID-19 and the heart.

But the biggest discussion points related to the COVID-19 pandemic today? Nicole Bhave, M.D., a cardiologist and echocardiographer, says although the situation has evolved over time "the diverse spectrum of ways COVID can affect the heart; not only during the acute illness, but also during the recovery period," remains a hot topic.

And Geoffrey Barnes, M.D., M.Sc., a cardiologist and vascular medicine expert, agrees, saying blood clots have also been a top concern, with patients often calling with questions about it.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

"Am I going to get a blood clot if I get COVID or if I take the COVID vaccine? If do have a blood clot, what am I supposed to do to treat it or what do I do to prevent it? If I take blood thinners for one reason is it safe to take the vaccine or what's it going to mean for me if I get COVID?" says Barnes. "Those are a lot of the questions I tend to hear from my patients, and [questions] that my colleagues and I are discussing."

In a recent Facebook live stream, posted above, both Barnes and Bhave address what to know about the virus's effects on the heart and blood vessels and what they want current heart patients to be aware of in terms of the virus and the COVID-19 vaccines.

Click the question below you're interested in learning more about to jump to that section in the video above:

Like Podcasts? Add the Michigan Medicine News Break on iTunes, Google Podcast or anywhere you listen to podcasts.


More Articles About: Heart Health Cardiovascular: Diseases & Conditions Cardiovascular: Preventive Cardiology Covid-19 infectious disease
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of healthcare news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories heart organ yellow blue
Health Lab
Around 10% of deaths from coronary stenting, balloon angioplasty are preventable
Around 10% of all deaths following percutaneous coronary intervention are potentially preventable, a study led by Michigan Medicine finds.
Enlargement of microscopic HIV virus cells
Health Lab
Researchers open new leads in anti-HIV drug development, using compound found in nature
Researchers open new leads in anti-HIV drug development, using a compound found in nature
Microscopic image of bone marrow with pink and white hues
Health Lab
Novel risk score for cardiovascular complications after bone marrow transplant
More bone marrow transplants, also known as hematopoietic stem cell transplantation, are being offered to older patients, a population at greater risk of cardiovascular disease.
dna strand
Health Lab
Female genetic markers may have greater effect on hypertension, certain cardiovascular diseases
Female genetic markers may have greater effect on hypertension, certain cardiovascular diseases
Person's hand holding an aspirin tablet with a glass of water nearby
Health Lab
An aspirin a day? Some older adults who take it may be following outdated advice
Many people aged 50 to 80 who said they take aspirin multiple times a week may not need to do so and could be causing health risks, according to National Poll on Healthy Aging.
Pink, blue, purple illustration of COVID-19 virus
Health Lab
Four years later, what do we know about COVID-19?
Today, thanks to researchers, medical and public health experts, pharmaceutical companies, engineers and others, we know more and can do more about the coronavirus called SARS-CoV2, and the disease called COVID-19, than ever before.